Miguel Angel Asin

Title: Innovations by Miguel Angel Asin: Pioneering Biodegradable Microspheres

Introduction

Miguel Angel Asin, an innovative inventor based in Cerdanyola del Valles, Spain, has made significant contributions to the field of pharmaceuticals. With two patents to his name, Asin is recognized for developing advanced methods that enhance drug delivery systems. His work plays a crucial role in improving the effectiveness of pharmaceutical compositions.

Latest Patents

Asin's latest patents focus on the creation of prolonged release biodegradable microspheres and the method for preparing them. The invention details a comprehensive method for producing a pharmaceutical composition characterized by microspheres that ensure a prolonged release of a water-soluble active principle. The process entails several steps: dissolving the active principle in water, emulsifying it with a d,l-lactide-co-glycolide copolymer, and extracting the solvent to yield microspheres. These microspheres are designed for continuous release over more than two months, specifically targeting advantageous durations of at least three months, highlighting the patent's significance in providing long-lasting therapeutic effects.

Career Highlights

Asin is associated with Pierre Fabre Medicament, a prominent company in the pharmaceutical sector. His career at Pierre Fabre has allowed him to refine his innovative approaches and contribute to the development of advanced biopharmaceutical technologies. His discoveries exemplify the integration of science and practical applications in medicine.

Collaborations

Throughout his career, Asin has collaborated with talented colleagues, such as Rosa Arola and Eulalia Ferret. These partnerships have enriched his research and fostered an environment of innovation and creativity, aiding in the successful realization of his projects.

Conclusion

In summary, Miguel Angel Asin's work in the pharmaceutical field exemplifies the power of innovation through his patented methods for biodegradable microspheres. His expertise and collaborative efforts continue to influence the pharmaceutical industry, offering enhanced drug delivery methods that contribute to improved patient outcomes.